SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367920-21-000059
Filing Date
2021-08-05
Accepted
2021-08-05 07:09:18
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnce-20210630.htm   iXBRL 10-Q 1520056
2 EX-31.1 q22021exhibit311.htm EX-31.1 10681
3 EX-31.2 q22021exhibit312.htm EX-31.2 10647
4 EX-32.1 q22021exhibit321.htm EX-32.1 6154
5 EX-32.2 q22021exhibit322.htm EX-32.2 6079
  Complete submission text file 0001367920-21-000059.txt   6123394

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnce-20210630.xsd EX-101.SCH 32347
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnce-20210630_cal.xml EX-101.CAL 60519
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnce-20210630_def.xml EX-101.DEF 162613
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnce-20210630_lab.xml EX-101.LAB 495916
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnce-20210630_pre.xml EX-101.PRE 320589
11 EXTRACTED XBRL INSTANCE DOCUMENT cnce-20210630_htm.xml XML 985128
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36310 | Film No.: 211146270
SIC: 2834 Pharmaceutical Preparations